Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Metastatic HER2 Positive Gastroesophageal Junction Cancer

Tundra lists 1 Metastatic HER2 Positive Gastroesophageal Junction Cancer clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06650332

Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients

This trial is An open-label, multicohort, multicenter clinical study aimed at evaluating the efficacy and safety of the cadonilimab combination regimen in the treatment of advanced HER-2 positive gastric/gastroesophageal junction tumors

Gender: All

Ages: 18 Years - 75 Years

Updated: 2024-10-21

1 state

Metastatic HER2 Positive Gastroesophageal Junction Cancer